RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
1-Year Return 25.98%
This Quarter Return
+33.41%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.57B
AUM Growth
+$452M
Cap. Flow
-$55.1M
Cap. Flow %
-2.14%
Top 10 Hldgs %
31.92%
Holding
139
New
6
Increased
46
Reduced
13
Closed
9
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SGEN
51
DELISTED
Seagen Inc. Common Stock
SGEN
$17.7M 0.68%
242,000
+39,500
+20% +$2.89M
CELG
52
DELISTED
Celgene Corp
CELG
$17.5M 0.67%
185,150
FGEN icon
53
FibroGen
FGEN
$48.9M
$16.6M 0.64%
12,240
ALLK
54
DELISTED
Allakos
ALLK
$16.4M 0.63%
404,000
IMMU
55
DELISTED
Immunomedics Inc
IMMU
$15.4M 0.59%
800,000
+20,000
+3% +$384K
XENT
56
DELISTED
Intersect ENT, Inc
XENT
$15M 0.58%
465,000
SAGE
57
DELISTED
Sage Therapeutics
SAGE
$14.7M 0.57%
92,500
+43,500
+89% +$6.92M
A icon
58
Agilent Technologies
A
$36.5B
$14.7M 0.57%
182,800
CI icon
59
Cigna
CI
$81.5B
$14.5M 0.56%
+90,000
New +$14.5M
OBSV
60
DELISTED
ObsEva SA Ordinary Shares
OBSV
$14.3M 0.55%
1,120,000
GH icon
61
Guardant Health
GH
$7.5B
$13.8M 0.53%
180,000
-36,000
-17% -$2.76M
WST icon
62
West Pharmaceutical
WST
$18B
$13.8M 0.53%
125,000
-35,000
-22% -$3.86M
FOLD icon
63
Amicus Therapeutics
FOLD
$2.46B
$13.6M 0.52%
1,000,000
BHVN
64
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$13.4M 0.52%
260,000
MRTX
65
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$13.2M 0.51%
180,000
+30,000
+20% +$2.2M
GBT
66
DELISTED
Global Blood Therapeutics, Inc.
GBT
$13M 0.5%
245,000
ZGNX
67
DELISTED
Zogenix, Inc.
ZGNX
$12.9M 0.5%
235,000
AXGN icon
68
Axogen
AXGN
$735M
$12.7M 0.49%
603,970
TBPH icon
69
Theravance Biopharma
TBPH
$703M
$12.5M 0.48%
550,000
ANAB icon
70
AnaptysBio
ANAB
$613M
$12.4M 0.48%
170,000
+34,000
+25% +$2.48M
ZLAB icon
71
Zai Lab
ZLAB
$3.42B
$12.2M 0.47%
413,400
+63,400
+18% +$1.87M
BMRN icon
72
BioMarin Pharmaceuticals
BMRN
$11.1B
$12M 0.46%
135,000
+6,000
+5% +$533K
SRGA
73
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$11.7M 0.45%
65,000
PHAS
74
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$10.8M 0.42%
1,140,000
+305,000
+37% +$2.9M
RIGL icon
75
Rigel Pharmaceuticals
RIGL
$742M
$10.8M 0.42%
420,000